Funding for this research was provided by:
French Ministry of Health (Inter-regional Hospital Clinical Research Program 2019)
Received: 26 August 2022
Accepted: 12 September 2022
First Online: 22 September 2022
: The GO NEUTRAL study (protocol version 1) was approved by a human research ethics committee (Comité de Protection des Personnes Sud-Méditerranée I) on April 29, 2021, under the reference number IDRCB 2021-A00692-39 (Supplemental Material InternalRef removed for the French and English versions). The trial received authorization to start from the French regulatory agency (Agence National de Sécurité du Médicament) on May 27, 2021.Written informed consent will be obtained from all participants and/or their legal representative if the participant is in a medical condition that does not allow informed consent. A model consent form will be provided upon request to the corresponding author.
: Not applicable. No clinical details of trial participants are presented in the present article or will be presented in reports of the trial results.
: The authors declare they have no competing interests.